Versant Capital Management’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.8K | Buy |
340
+263
| +342% | +$47.7K | 0.01% | 1073 |
|
|
2026
Q1 | $10.3K | Buy |
77
+47
| +157% | +$7.48K | ﹤0.01% | 2132 |
|
|
2025
Q4 | $5.21K | Sell |
30
-2,096
| -99% | -$345K | ﹤0.01% | 2242 |
|
|
2025
Q3 | $407K | Buy |
2,126
+1,424
| +203% | +$262K | 0.06% | 252 |
|
|
2025
Q2 | $209K | Sell |
702
-228
| -25% | -$71.6K | 0.03% | 433 |
|
|
2025
Q1 | $306K | Buy |
930
+767
| +471% | +$232K | 0.05% | 284 |
|
|
2024
Q4 | $47.4K | Buy |
163
+74
| +83% | +$22.9K | 0.01% | 601 |
|
|
2024
Q3 | $30.7K | Buy |
89
+65
| +271% | +$21.4K | 0.01% | 629 |
|
|
2024
Q2 | $7.13K | Buy |
24
+19
| +380% | +$6.45K | ﹤0.01% | 1101 |
|
|
2024
Q1 | $2.05K | Hold |
5
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q4 | $1.81K | Hold |
5
| – | – | ﹤0.01% | 1322 |
|
|
2023
Q3 | $1.64K | Hold |
5
| – | – | ﹤0.01% | 1370 |
|
|
2023
Q2 | $1.51K | Sell |
5
-3
| -38% | -$862 | ﹤0.01% | 1475 |
|
|
2023
Q1 | $2.14K | Buy |
8
+2
| +33% | +$575 | ﹤0.01% | 1262 |
|
|
2022
Q4 | $1.98K | Hold |
6
| – | – | ﹤0.01% | 1151 |
|
|
2022
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 1099 |
|
|
2022
Q2 | $2K | Buy |
6
+2
| +50% | +$604 | ﹤0.01% | 1115 |
|
|
2022
Q1 | $1K | Buy |
4
+1
| +33% | +$308 | ﹤0.01% | 1319 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 1305 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1316 |
|
|
2021
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 1319 |
|
|
2021
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 1395 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1457 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1423 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1459 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1542 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1499 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1508 |
|
|
2019
Q2 | $0 | Sell |
3
-17
| -85% | -$2.33K | ﹤0.01% | 1592 |
|
|
2019
Q1 | $2K | Sell |
20
-79
| -80% | -$10.7K | ﹤0.01% | 1343 |
|
|
2018
Q4 | $11K | Hold |
99
| – | – | 0.01% | 785 |
|
|
2018
Q3 | $14K | Sell |
99
-22
| -18% | -$2.81K | 0.01% | 786 |
|
|
2018
Q2 | $11K | Hold |
121
| – | – | ﹤0.01% | 859 |
|
|
2018
Q1 | $9K | Sell |
121
-15
| -11% | -$1.21K | ﹤0.01% | 919 |
|
|
2017
Q4 | $10K | Hold |
136
| – | – | ﹤0.01% | 915 |
|
|
2017
Q3 | $9K | Sell |
136
-12
| -8% | -$781 | ﹤0.01% | 897 |
|
|
2017
Q2 | $10K | Sell |
148
-2
| -1% | -$123 | 0.01% | 875 |
|
|
2017
Q1 | $6K | Sell |
150
-9
| -6% | -$471 | ﹤0.01% | 997 |
|
|
2016
Q4 | $8K | Hold |
159
| – | – | ﹤0.01% | 901 |
|
|
2016
Q3 | $9K | Buy |
159
+3
| +2% | +$165 | 0.01% | 852 |
|
|
2016
Q2 | $7K | Hold |
156
| – | – | ﹤0.01% | 890 |
|
|
2016
Q1 | $10K | Hold |
156
| – | – | 0.01% | 764 |
|
|
2015
Q4 | $9K | Buy |
+156
| New | +$9.83K | 0.01% | 771 |
|
Other funds holding MOH
LMFP
AIM
ACM
MFG
YCM
CWM
Versant Capital Management's MOH Position: Q2 2026 in Review
Versant Capital Management increased its Molina Healthcare (MOH) stake by 342% in Q2 2026, buying an estimated $47.7K and bringing the position to 340 shares worth $77.8K. The position accounts for 0.01% of the portfolio, ranked #1073.
Versant Capital Management first reported a position in MOH in Q4 2015 and has held it in 43 quarters since. The position peaked at $407K in Q3 2025. 66 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- Versant Capital Management held 340 shares of Molina Healthcare worth $77.8K as of Q2 2026.
- Versant Capital Management bought 263 Molina Healthcare shares in Q2 2026, an estimated $47.7K.
- Molina Healthcare made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1073 holding.
- Versant Capital Management first reported a position in Molina Healthcare in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's Molina Healthcare position peaked at $407K in Q3 2025.
- 66 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.